Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01019343 · ClinicalTrials.gov registry record · NA

Physiological Investigations of Movement Disorders

A NA study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
NA
Development phase
1,273
Enrollment target

NCT01019343 is a NA study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 1,273 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01019343, a NA study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
NA
Development phase
1,273 participants
Enrollment target

Study Summary

Background: * Previous studies have given researchers information on how the brain controls movement, how people learn to make fine, skilled movements, and why some people have movement disorders. However, further research is needed to learn more about the causes of most movement disorders, such as Parkinson's disease. * By using small, specialized studies to evaluate people with movement disorders and compare them with healthy volunteers, researchers hope to learn more about the changes in the brain and possible causes of movement disorders. Objectives: * To better understand how the brain controls movement. * To learn more about movement disorders. * To train movement disorder specialists. Eligibility: * Individuals 18 years of age or older who have had a movement disorder diagnosed by a neurologist and are able to participate based on the specific requirements of the small study. * Healthy volunteers 18 years of age or older. Design: * Participants will have a screening visit with medical history, physical examination, and questionnaire to determine eligibility. Eligible participants will give consent to participate in up to seven additional outpatient visits for study procedures. The number of sessions and the procedures needed for participation depend on specific symptoms. * Participants must avoid drinking alcohol or caffeinated drinks (sodas, coffee, and tea) for at least 2 days (48 hours) before each session. * Potential studies may include magnetic resonance imaging (MRI) scans, functional MRI scans, electroencephalography, magnetoencephalography, transcranial magnetic stimulation, nerve and sensory stimulation, or movement and mental tasks during any of the above procedures. * This study does not provide treatment for movement disorders. Participants will not have to stop any treatment in order to participate.

Interventions

  • PROCEDURE Transcranial Direct Current Stimulation (tDCS)
  • DEVICE Eye-tracking Device
  • DEVICE Pulsed vibrator
  • OTHER Gait Trainer Treadmill (GTT)
  • OTHER Standard psychiatric scales SCID-I, YBOCS and SCI-OBS-lifetime and cognitive scales MMSE and MOCA

Trial Details

FieldValue
Enrollment Target 1,273 participants
Start Date 2009-12-08
Est. Completion 2020-10-09
Phase NA

What the Registry Record Tells You About NCT01019343

The ClinicalTrials.gov registry entry for NCT01019343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,273 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Transcranial Direct Current Stimulation (tDCS) is the first listed.

NCT01019343 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01019343 about?

NCT01019343 is a clinical study titled "Physiological Investigations of Movement Disorders". Background: * Previous studies have given researchers information on how the brain controls movement, how people learn to make fine, skilled movements, and why some people have movement disorders. However, further research is needed to learn more about the causes of most movement disorders, such as...

What is the current status of trial NCT01019343?

This trial is currently completed. It is a NA study. The enrollment target is 1,273 participants. The study started on 2009-12-08. Estimated completion is 2020-10-09.

What interventions are being tested in trial NCT01019343?

The interventions under investigation include: Transcranial Direct Current Stimulation (tDCS) (PROCEDURE), Eye-tracking Device (DEVICE), Pulsed vibrator (DEVICE), Gait Trainer Treadmill (GTT) (OTHER), Standard psychiatric scales SCID-I, YBOCS and SCI-OBS-lifetime and cognitive scales MMSE and MOCA (OTHER).

Who is sponsoring clinical trial NCT01019343?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.